These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17191946)

  • 1. Rational design and development of radiation-sensitizing histone deacetylase inhibitors.
    Jung M; Kozikowski A; Dritschilo A
    Chem Biodivers; 2005 Nov; 2(11):1452-61. PubMed ID: 17191946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bmf contributes to histone deacetylase inhibitor-mediated enhancing effects on apoptosis after ionizing radiation.
    Zhang Y; Adachi M; Kawamura R; Zou HC; Imai K; Hareyama M; Shinomura Y
    Apoptosis; 2006 Aug; 11(8):1349-57. PubMed ID: 16830229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational development of histone deacetylase inhibitors as anticancer agents: a review.
    Acharya MR; Sparreboom A; Venitz J; Figg WD
    Mol Pharmacol; 2005 Oct; 68(4):917-32. PubMed ID: 15955865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel HDAC inhibitors with radiosensitizing properties.
    Jung M; Velena A; Chen B; Petukhov PA; Kozikowski AP; Dritschilo A
    Radiat Res; 2005 May; 163(5):488-93. PubMed ID: 15850409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors.
    Anandan SK; Ward JS; Brokx RD; Denny T; Bray MR; Patel DV; Xiao XY
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5995-9. PubMed ID: 17827005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.
    Zhang Y; Jung M; Dritschilo A; Jung M
    Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cellular radiation responses by histone deacetylase inhibitors.
    Karagiannis TC; El-Osta A
    Oncogene; 2006 Jun; 25(28):3885-93. PubMed ID: 16462761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells.
    Bar-Sela G; Jacobs KM; Gius D
    Cancer J; 2007; 13(1):65-9. PubMed ID: 17464248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
    Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
    Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of histone deacetylase inhibitors for cancer treatment.
    Marchion D; Münster P
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):583-98. PubMed ID: 17428177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
    Chung YL; Lee MY; Pui NN
    Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of checkpoint responses to histone deacetylase inhibitors.
    Beamish H; Warrener R; Gabrielli BG
    Methods Mol Biol; 2004; 281():245-59. PubMed ID: 15220534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel small-molecule histone deacetylase inhibitors by medium-throughput screening using a fluorigenic assay.
    Wegener D; Hildmann C; Riester D; Schober A; Meyer-Almes FJ; Deubzer HE; Oehme I; Witt O; Lang S; Jaensch M; Makarov V; Lange C; Busse B; Schwienhorst A
    Biochem J; 2008 Jul; 413(1):143-50. PubMed ID: 18384290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc binding in HDAC inhibitors: a DFT study.
    Wang D; Helquist P; Wiest O
    J Org Chem; 2007 Jul; 72(14):5446-9. PubMed ID: 17579460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors--turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases.
    Riester D; Hildmann C; Schwienhorst A
    Appl Microbiol Biotechnol; 2007 Jun; 75(3):499-514. PubMed ID: 17377788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells.
    Sakimura R; Tanaka K; Yamamoto S; Matsunobu T; Li X; Hanada M; Okada T; Nakamura T; Li Y; Iwamoto Y
    Clin Cancer Res; 2007 Jan; 13(1):275-82. PubMed ID: 17200366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors preferentially augment transient transgene expression in human dermal fibroblasts.
    Yasukawa K; Sawamura D; Goto M; Nakamura H; Shimizu H
    Br J Dermatol; 2007 Oct; 157(4):662-9. PubMed ID: 17711521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors: biology and mechanism of action.
    Mehnert JM; Kelly WK
    Cancer J; 2007; 13(1):23-9. PubMed ID: 17464243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel series of potent and selective ketone histone deacetylase inhibitors with antitumor activity in vivo.
    Jones P; Altamura S; De Francesco R; Paz OG; Kinzel O; Mesiti G; Monteagudo E; Pescatore G; Rowley M; Verdirame M; Steinkühler C
    J Med Chem; 2008 Apr; 51(8):2350-3. PubMed ID: 18370373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.